Showing results (251-260 of 310) with videos related to

Sort By:
Pageof 31
Neuroscience Letters|May 12, 2006
Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson's diseaseS W Lim, Y Zhao, E Chua, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerS H Lim, M Hong, S Ahn, et al.
Resuscitation|April 22, 2018
"All citizens of the world can save a life" - The World Restart a Heart (WRAH) initiative starts in 2018B W Böttiger, A Lockey, R Aickin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of diseaseS H Lim, J Y Hong, S T Lim, et al.
Bone Marrow Transplantation|February 9, 2016
Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTLS H Lim, S H Hyun, H S Kim, et al.
Cancer Gene Therapy|August 27, 2011
Therapeutic targeting of subdural medulloblastomas using human neural stem cells expressing carboxylesteraseS-H Lim, S A Choi, J Y Lee, et al.
ANZ Journal of Surgery|April 26, 2022
Male breast cancer: a Singapore perspectiveJoshua S H Lim, Yirong Sim, Joanne Ngeow, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: the COALA projectN Hitchen, H-L Wong, R Wong, et al.
British Journal of Cancer|October 28, 2015
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancerS H Lim, T W Kim, Y S Hong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 25, 2014
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerS H Lim, J Y Lee, M-Y Lee, et al.
Pageof 31